Long‐term safety and efficacy results of taliglucerase alfa up to 36 months in adult treatment‐naïve patients with Gaucher disease
This article is protected by copyright. All rights reserved.
Source: American Journal of Hematology - Category: Hematology Authors: Ari Zimran, Gloria Durán, Atul Mehta, Pilar Giraldo, Hanna Rosenbaum, Fiorina Giona, Dominick J. Amato, Milan Petakov, Eduardo Terreros Muñoz, Sergio Eduardo Solorio‐Meza, Peter A. Cooper, Sheeba Varughese, Raul Chertkoff, Einat Brill‐Almon Tags: Research Article Source Type: research
More News: Common Cold | Gaucher's Disease | Headache | Hematology | Hypertension | Liver | Migraine | Pain | Respiratory Medicine | Urology & Nephrology